Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: Can we rely on large randomized control trials in the era of personalized medicine?

S. Glück

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1937-1938
Number of pages2
JournalAnnals of Oncology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Precision Medicine
Estrogen Receptor Modulators
Adjuvant Chemotherapy
Methotrexate
Fluorouracil
Estrogen Receptors
Cyclophosphamide
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

@article{2480e6c87e854cfb951fbc2b08b1b357,
title = "Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: Can we rely on large randomized control trials in the era of personalized medicine?",
author = "S. Gl{\"u}ck",
year = "2011",
month = "9",
day = "1",
doi = "10.1093/annonc/mdr338",
language = "English",
volume = "22",
pages = "1937--1938",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer

T2 - Can we rely on large randomized control trials in the era of personalized medicine?

AU - Glück, S.

PY - 2011/9/1

Y1 - 2011/9/1

UR - http://www.scopus.com/inward/record.url?scp=80052398406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052398406&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr338

DO - 10.1093/annonc/mdr338

M3 - Article

C2 - 21765047

AN - SCOPUS:80052398406

VL - 22

SP - 1937

EP - 1938

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -